Wednesday, October 31, 2018

Orchard Therapeutics 14.3M share IPO priced at $14.00


The deal was upsized from 13.33M and priced at the low end of the $14.00-$16.00 range. JPMorgan, Goldman Sachs, Cowen and Wedbush are acting as joint book running managers for the offering.
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.